iNtRON Biotechnology Market Cap

iNtRON Biotechnology has a market cap or net worth of 167.99 billion as of March 9, 2026. Its market cap has decreased by -6.19% in one year.

Market Cap

167.99B

Enterprise Value

133.06B

Revenue

5.56B

Ranking

n/a

PE Ratio

n/a

Stock Price

5,480.00

Market Cap Chart

Since January 26, 2011, iNtRON Biotechnology's market cap has increased from 95.30B to 167.99B, an increase of 76.28%. That is a compound annual growth rate of 3.82%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	197.72B	92.44%
Dec 30, 2025	102.75B	-44.03%
Dec 30, 2024	183.56B	-37.01%
Dec 28, 2023	291.42B	7.98%
Dec 29, 2022	269.88B	-61.99%
Dec 30, 2021	710.00B	-22.41%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vaxcell-Bio Therapeutics	195.83B
Macrogen	185.06B
ENCell	177.52B
MedPacto	174.46B
Genexine	231.04B
EASY BIO,Inc.	233.89B
HLB Therapeutics	241.80B
Helixmith	294.70B

Market Cap Rankings